Transcription of Public Assessment Report Mutual Recognition …
{{id}} {{{paragraph}}}
Example: biology
Public Assessment Report Mutual Recognition …
PAR Sayana 104 Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104 SUSPENSION FOR INJECTION UK/H/0960/001/MR UK licence no: PL 00057/0589 Pfizer Limited PAR Sayana 104 Suspension for Injection UK/H/0960/001/MR 2 SAYANA 104 SUSPENSION FOR INJECTION LAY SUMMARY On 9th July 2007, Austria, Belgium, Czech Republic, Germany, Hungary, Ireland, The Netherlands, Norway and Poland granted Marketing Authorisations to Pfizer Limited for the medicinal product Sayana 104 Suspension for Injection. The licences were granted by Mutual Recognition Procedure (MRP), with the UK as Reference Member State (RMS).
PAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Public Assessment Report Repeat-Use Mutual, Public Assessment Report . Repeat-Use Mutual Recognition Procedure, Assessment of Periodic, Assessment of periodic safety, OECD REGULATORY, MUTUAL RECOGNITION, The Mutual Recognition and Decentralised Procedures, Justice in South Africa: Children, REPORT, Justice in South Africa: Children’s Rights Under Construction, WHO Drug Information, Out of Character, National Qualifications Framework